Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| KalVista Pharmaceuticals, Inc. | 479 989 | déclaré | 22 mai 2026 | tx 161+2 810 090−978 345 |
| PENWEST PHARMACEUTICALS CO | 19 500 | déclaré | 11 juin 2008 | tx 8+342 500 |
| GENE LOGIC INC | 6 250 | déclaré | 18 janv. 2010 | tx 3+246 250 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 21 mai 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 23 250 | — | |
| 22 mai 2026 | SALE | KalVista Pharmaceuticals, Inc. | 10 926 | 26.78 USD | |
| 21 mai 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 23 250 | 0.00 USD | deriv |
| 17 mai 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 2 419 | — | |
| 18 mai 2026 | SALE | KalVista Pharmaceuticals, Inc. | 1 129 | 26.76 USD | |
| 17 mai 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 2 419 | 0.00 USD | deriv |
| 11 mai 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 7 120 | — | |
| 12 mai 2026 | SALE | KalVista Pharmaceuticals, Inc. | 3 322 | 26.71 USD | |
| 11 mai 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 7 120 | 0.00 USD | deriv |
| 17 avr. 2026 | SALE | KalVista Pharmaceuticals, Inc. | 9 550 | 20.22 USD | |
| 16 avr. 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 20 312 | — | |
| 16 avr. 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 20 312 | 0.00 USD | deriv |
| 06 mars 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 15 625 | — | |
| 09 mars 2026 | SALE | KalVista Pharmaceuticals, Inc. | 6 693 | 16.08 USD | |
| 06 mars 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 15 625 | 0.00 USD | deriv |
| 23 févr. 2026 | SALE | KalVista Pharmaceuticals, Inc. | 10 034 | 15.57 USD | |
| 21 févr. 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 23 250 | — | |
| 21 févr. 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 23 250 | 0.00 USD | deriv |
| 18 févr. 2026 | SALE | KalVista Pharmaceuticals, Inc. | 1 038 | 15.00 USD | |
| 17 févr. 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 2 419 | — | |
| 17 févr. 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 2 419 | 0.00 USD | deriv |
| 12 févr. 2026 | SALE | KalVista Pharmaceuticals, Inc. | 3 354 | 15.70 USD | |
| 11 févr. 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 7 120 | — | |
| 11 févr. 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 7 120 | 0.00 USD | deriv |
| 16 janv. 2026 | GRANT_AWARD | KalVista Pharmaceuticals, Inc. | 325 000 | 0.00 USD | deriv |